Fasenra Pediatric Japan Post-Marketing Study(PMS)

Trial Identifier:	D3250C00100
Sponsor:	AstraZeneca
Start Date:	July 2024
Primary Completion Date:	March 2027
Study Completion Date:	March 2027
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Aichi, Japan
Japan	Chiba, Japan
Japan	Hiroshima, Japan
Japan	Hokkaido, Japan
Japan	Hyogo, Japan
Japan	Ibaraki, Japan
Japan	Mie, Japan
Japan	Okayama, Japan
Japan	Osaka, Japan
Japan	Saitama, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.